BOIRF (Boiron) Cash Flow for Dividends: $-24.0 Mil (TTM As of Dec. 2025)


BOIRF Boiron SA BOIRF
62 GF Score
Price $31.90
GF Value $33.65
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Boiron Cash Flow for Dividends?

Boiron BOIRF 62 Cash Flow for Dividends is $-24.0 Mil as of Dec. 2025. GuruFocus rates BOIRF with a GF Score™ of 62/100 and a GF Value™ of $33.65 (Fairly Valued). The stock has 5 warning signs investors should review.

Boiron's cash flow for dividends for the six months ended in Dec. 2025 was $0.0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Dec. 2025 was $-24.0 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Boiron's quarterly payment of dividends increased from Dec. 2024 ($0.0 Mil) to Jun. 2025 ($-24.0 Mil) but then declined from Jun. 2025 ($-24.0 Mil) to Dec. 2025 ($0.0 Mil).

Boiron's annual payment of dividends declined from Dec. 2023 ($-217.0 Mil) to Dec. 2024 ($-24.5 Mil) and declined from Dec. 2024 ($-24.5 Mil) to Dec. 2025 ($-24.4 Mil).

Boiron Cash Flow for Dividends Related Terms

Boiron Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for Boiron's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Boiron Cash Flow for Dividends Chart

Boiron Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only -18.81 -17.48 -216.98 -24.54 -24.40

Boiron Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -196.15 -25.23 0.00 -24.03 0.00
BOIRF
62GF Score
Boiron SA BOIRF
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Boiron Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-24.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of $-24.0 Mil mean?
Boiron (BOIRF) has a Cash Flow for Dividends of $-24.0 Mil as of Dec. 2025. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Boiron and its competitors.
Is Boiron's Cash Flow for Dividends too high?
Boiron's current Cash Flow for Dividends is $-24.0 Mil. Overall, Boiron has a GF Score™ of 62/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Boiron's Cash Flow for Dividends compare to ZTS and UTHR?
Boiron's Cash Flow for Dividends of $-24.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Drug Manufacturers company?
A good Cash Flow for Dividends depends on the Drug Manufacturers industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Boiron and its competitors. Boiron's current Cash Flow for Dividends is $-24.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Boiron stock overvalued right now?
Based on GuruFocus' analysis, Boiron (BOIRF) is currently considered Fairly Valued. The stock's GF Value™ is $33.65, compared to a current price of $31.90 — trading 5.2% below its estimated fair value. The current Cash Flow for Dividends is $-24.0 Mil. Boiron's overall GF Score™ is 62/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For Boiron (BOIRF), the current Cash Flow for Dividends is $-24.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Boiron (BOIRF) Overvalued in 2026?

Based on GuruFocus' analysis, Boiron stock appears to be undervalued. The current stock price of $31.90 is trading 5.2% below its estimated GF Value™ of $33.65. GuruFocus considers Boiron to be Fairly Valued.

Key valuation signals for BOIRF:

  • Cash Flow for Dividends: $-24.0 Mil
  • GF Value™: $33.65 vs. price of $31.90 (5.2% below fair value)
  • GF Score™: 62/100 with 5 warning signs

No single metric tells the full story. See the BOIRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Boiron Business Description

Address 2, Avenue de l’Ouest Lyonnais No. 039, Messimy, FRA, 69510
Boiron SA is a drug manufacturer that focuses on homeopathic products. The company's revenue is roughly split between its nonproprietary homeopathic medicines and products in its over-the-counter specialties category. Boiron's nonproprietary medicines are generic products that do not refer to any therapeutic indication, while the specialties category includes first-resort products provided in tablet form, are bottled to use as drops, syrups, or ointments. Geographical segments are France, Europe, North America, and other countries. It generates a majority of revenue from France. The company's products include Oscillococcinum, Stodal and Stodaline, Arnigel, Camilia, Sedatif PC, Coryzalia, Homeoptic, and Homeovox.
62GF Score

Get the complete analysis for BOIRF

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$31.90
Price
$33.65
GF Value